206 related articles for article (PubMed ID: 25256133)
1. Subjective cognitive concerns, episodic memory, and the APOE ε4 allele.
Samieri C; Proust-Lima C; M Glymour M; Okereke OI; Amariglio RE; Sperling RA; Rentz DM; Grodstein F
Alzheimers Dement; 2014 Nov; 10(6):752-759.e1. PubMed ID: 25256133
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E and change in episodic memory in blacks and whites.
Barnes LL; Arvanitakis Z; Yu L; Kelly J; De Jager PL; Bennett DA
Neuroepidemiology; 2013; 40(3):211-9. PubMed ID: 23364031
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
Caselli RJ; Dueck AC; Osborne D; Sabbagh MN; Connor DJ; Ahern GL; Baxter LC; Rapcsak SZ; Shi J; Woodruff BK; Locke DE; Snyder CH; Alexander GE; Rademakers R; Reiman EM
N Engl J Med; 2009 Jul; 361(3):255-63. PubMed ID: 19605830
[TBL] [Abstract][Full Text] [Related]
4. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E and Its Association With Cognitive Change and Modification of Treatment Effects of Vitamin D3 and Omega-3s on Cognitive Change: Results From the In-Clinic Subset of a Randomized Clinical Trial.
Vyas CM; Kang JH; Mischoulon D; Cook NR; Reynolds Iii CF; Chang G; Mora S; De Vivo I; Manson JE; Okereke OI
J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 37952113
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course.
Rawle MJ; Davis D; Bendayan R; Wong A; Kuh D; Richards M
Transl Psychiatry; 2018 Jan; 8(1):18. PubMed ID: 29317609
[TBL] [Abstract][Full Text] [Related]
8. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
9. When time's arrow doesn't bend: APOE-ε4 influences episodic memory before old age.
Eich TS; Tsapanou A; Stern Y
Neuropsychologia; 2019 Oct; 133():107180. PubMed ID: 31473197
[TBL] [Abstract][Full Text] [Related]
10. Education, APOE ε4, and Cognition in Individuals with Subjective Cognitive Decline with Worry in the SILCODE Study.
Chen G; Lin L; Yang K; Han Y
Curr Alzheimer Res; 2021; 18(6):492-498. PubMed ID: 34598665
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
[TBL] [Abstract][Full Text] [Related]
13. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
[TBL] [Abstract][Full Text] [Related]
14. The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Eepsilon4 carriers and non-carriers.
Sohrabi HR; Bates KA; Rodrigues M; Taddei K; Martins G; Laws SM; Lautenschlager NT; Dhaliwal SS; Foster JK; Martins RN
J Alzheimers Dis; 2009; 17(1):69-79. PubMed ID: 19494432
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
16. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study.
Dore GA; Elias MF; Robbins MA; Elias PK; Nagy Z
Diabetologia; 2009 Dec; 52(12):2551-60. PubMed ID: 19693485
[TBL] [Abstract][Full Text] [Related]
17. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
18. APOE ε4 is associated with longer telomeres, and longer telomeres among ε4 carriers predicts worse episodic memory.
Wikgren M; Karlsson T; Nilbrink T; Nordfjäll K; Hultdin J; Sleegers K; Van Broeckhoven C; Nyberg L; Roos G; Nilsson LG; Adolfsson R; Norrback KF
Neurobiol Aging; 2012 Feb; 33(2):335-44. PubMed ID: 20395015
[TBL] [Abstract][Full Text] [Related]
19. Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe.
Westlye ET; Hodneland E; Haász J; Espeseth T; Lundervold A; Lundervold AJ
Neuroimage; 2012 Oct; 63(1):507-16. PubMed ID: 22796460
[TBL] [Abstract][Full Text] [Related]
20. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
